Philips Announced The Results Of A Health Economic Analysis Published In The Journal Of Neurointerventional Surgery Showing That The Direct-To-Angio Stroke Care Pathway Reduced Costs By An Average Of €2,848 (~$3,120) Per Patient
Portfolio Pulse from Benzinga Newsdesk
Philips announced that a health economic analysis published in the Journal of Neurointerventional Surgery showed that the Direct-To-Angio stroke care pathway reduced costs by an average of €2,848 (~$3,120) per patient.
June 14, 2023 | 8:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Philips' Direct-To-Angio stroke care pathway has been shown to reduce costs by an average of $3,120 per patient, potentially increasing demand for the product.
The health economic analysis demonstrates that Philips' Direct-To-Angio stroke care pathway can significantly reduce costs for healthcare providers. This cost reduction may lead to increased demand for the product, as providers seek to optimize their expenses. As a result, this news could have a positive short-term impact on Philips' stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100